Erratum to “Obstetrical outcomes and biomarkers to assess exposure to phthalates: A review” [Environment International 75 (2015): 116–136](S0160412015001312)(10.1016/j.envint.2015.06.003);Obstetrical outcomes and biomarkers to assess exposure to phthalates: A review

Environment International

Volumn 83, Issue , 2015, Pages 116-136

  Marie, Cécile ^a,b   Vendittelli, Françoise ^a,b,c   Sauvant Rochat, Marie Pierre ^b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Biomarker; Endocrine disrupters; In utero exposure; Phthalates; Pregnancy outcomes

Indexed keywords

ANTHROPOMETRY; BIOMOLECULES; ENDOCRINE DISRUPTERS; ESTERS; METABOLITES; OBSTETRICS;

CONGENITAL MALFORMATIONS; DIISONONYL PHTHALATE; EPIDEMIOLOGICAL STUDIES; EXPOSURE ASSESSMENT; METHODOLOGICAL APPROACH; PHTHALATES; PREGNANCY OUTCOMES; SUBSTITUTION PRODUCTS;

BIOMARKERS;

ANTIANDROGEN; BIOLOGICAL MARKER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; POLLUTANT;

BIOMARKER; ENDOCRINE DISRUPTOR; EPIDEMIOLOGY; METABOLITE; PHTHALATE; POLLUTION EXPOSURE; PREGNANCY;

AMNION FLUID ANALYSIS; ANOGENITAL DISTANCE; BIRTH WEIGHT; BODY HEIGHT; BODY SIZE; CONGENITAL MALFORMATION; CRYPTORCHISM; ENVIRONMENTAL EXPOSURE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; HYPOSPADIAS; MECONIUM; MILK; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; UMBILICAL CORD BLOOD; URINALYSIS; ADULT; CHEMICALLY INDUCED; FEMALE; MALE; MATERNAL EXPOSURE; POLLUTANT; PREGNANCY; PREGNANCY COMPLICATIONS; TOXICITY;

ADULT; BIOMARKERS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MATERNAL EXPOSURE; PHTHALIC ACIDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84934913581     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2015.08.010     Document Type: Erratum

References (115)

1. Adibi J.J., Whyatt R.M., Williams P.L., Calafat A.M., Camann D., Herrick R., et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ. Health Perspect. 2008, 116:467-473.
2. Adibi J.J., Hauser R., Williams P.L., Whyatt R.M., Calafat A.M., Nelson H., et al. Maternal urinary metabolites of di-(2-ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am. J. Epidemiol. 2009, 169:1015-1024.
3. Anand-Ivell R., Ivell R. Insulin-like factor 3 as a monitor of endocrine disruption. Reproduction 2014, 147:R87-R95.
4. Anand-Ivell R., Ivell R., Driscoll D., Manson J. Insulin-like factor 3 levels in amniotic fluid of human male fetuses. Hum. Reprod. 2008, 23:1180-1186.
5. Anderson W.A., Castle L., Hird S., Jeffery J., Scotter M.J. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate. Food Chem. Toxicol. 2011, 49:2022-2029.
6. Araki A., Mitsui T., Miyashita C., Nakajima T., Naito H., Ito S., et al. Association between maternal exposure to di(2-ethylhexyl) phthalate and reproductive hormone levels in fetal blood: the Hokkaido Study on Environment and Children's Health. PLoS ONE 2014, 9:e109039.
7. Audipog (Association des Utilisateurs de Dossiers Informatisés en Pédiatrie Obstétrique et Gynécologie): croissance fœtale et infantile Available at:, (Accessed on 5 November 2014). http://www.audipog.net/courbes_morpho.php.
8. Bahathiq A.O.S., Ledger W.L. Historical Background and Functional Anatomy. The Fallopian Tube in Infertility and IVF Practice 2010, 1-7. Cambridge University Press, (Available at: http://dx.doi.org/10.1017/CBO9780511750670.002 [Accessed on 25 February 2015]). W.L. Ledger, S.L. Tan, A.O.S. Bahathiq (Eds.).
9. Boberg J., Christiansen S., Axelstad M., Kledal T.S., Vinggaard A.M., Dalgaard M., et al. Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reprod. Toxicol. 2011, 31:200-209.
10. Borch J., Axelstad M., Vinggaard A.M., Dalgaard M. Diisobutyl phthalate has comparable anti-androgenic effects to di-n-butyl phthalate in fetal rat testis. Toxicol. Lett. 2006, 163:183-190.
11. Bornehag C.G., Carlstedt F., Jönsson B.A., Lindh C.H., Jensen T.K., Bodin A., et al. Prenatal phthalate exposures and anogenital distance in Swedish boys. Environ. Health Perspect. 2015, 123:101-107.
12. Braun J.M., Sathyanarayana S., Hauser R. Phthalate exposure and children's health. Curr. Opin. Pediatr. 2013, 25:247-254.
13. Brouwers M.M., van Tongeren M., Hirst A.A., Bretveld R.W., Roeleveld N. Occupational exposure to potential endocrine disruptors: further development of a job-exposure matrix. Occup. Environ. Med. 2009, 66:607-614.
14. Brucker-Davis F., Wagner-Mahler K., Delattre I., Ducot B., Ferrari P., Bongain A., et al. Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations. Hum. Reprod. Oxf Engl 2008, 23:1708-1718.
15. Brucker-Davis F., Wagner-Mahler K., Bornebusch L., Delattre I., Ferrari P., Gal J., et al. Exposure to selected endocrine disruptors and neonatal outcome of 86 healthy boys from Nice area (France). Chemosphere 2010, 81:169-176.
16. Buck Louis G.M., Sundaram R., Sweeney A.M., Schisterman E.F., Maisog J., Kannan K. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil. Steril. 2014, 101:1359-1366.
17. Burdorf A., Brand T., Jaddoe V.W., Hofman A., Mackenbach J.P., Steegers E.A.P. The effects of work-related maternal risk factors on time to pregnancy, preterm birth and birth weight: the Generation R Study. Occup. Environ. Med. 2011, 68:197-204.
18. Bustamante-Montes L.P., Hernández-Valero M.A., Flores-Pimentel D., García-Fábila M., Amaya-Chávez A., Barr D.B., et al. Prenatal exposure to phthalates is associated with decreased anogenital distance and penile size in male newborns. J. Dev. Orig. Health Dis. 2013, 4:300-306.
19. Calafat A.M., Needham L.L. Factors affecting the evaluation of biomonitoring data for human exposure assessment. Int. J. Androl. 2008, 31:139-143.
20. Cantonwine D.E., Cordero J.F., Rivera-Gonzalez L.O., Anzalota Del Toro L.V., Ferguson K.K., Mukherjee B., et al. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ. Int. 2014, 62:1-11.
21. Casteleyn L., Dumez B., Becker K., Kolossa-Gehring M., Den Hond E., Schoeters G., et al. A pilot study on the feasibility of European harmonized human biomonitoring: strategies towards a common approach, challenges and opportunities. Environ. Res. 2015, (in press).
22. Centers for Disease Control and Prevention (CDC) Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables. National Center for Environmental Health 2015, Department of Health and Human Services Centers for Disease Control and Prevention, Atlanta, (Available at: http://www.cdc.gov/exposurereport. [Accessed 28 March 2015]).
23. Challis J.R., Lockwood C.J., Myatt L., Norman J.E., Strauss J.F., Petraglia F. Inflammation and pregnancy. Reprod. Sci. 2009, 16:206-215.
24. Chevrier C., Petit C., Philippat C., Mortamais M., Slama R., Rouget F., et al. Maternal urinary phthalates and phenols and male genital anomalies. Epidemiology 2012, 23:353-356.
25. David R.M. Proposed mode of action for in utero effects of some phthalate esters on the developing male reproductive tract. Toxicol. Pathol. 2006, 34:209-219.
26. Dean A., Sharpe R.M. Clinical review: anogenital distance or digit length ratio as measures of fetal androgen exposure: relationship to male reproductive development and its disorders. J. Clin. Endocrinol. Metab. 2013, 98:2230-2238.
27. Dirtu A.C., Van den Eede N., Malarvannan G., Ionas A.C., Covaci A. Analytical methods for selected emerging contaminants in human matrices-a review. Anal. Bioanal. Chem. 2012, 404:2555-2581.
28. DiVall S.A. The influence of endocrine disruptors on growth and development of children. Curr. Opin. Endocrinol. Diabetes Obes. 2013, 20:50-55.
29. Esteban M., Castaño A. Non-invasive matrices in human biomonitoring: a review. Environ. Int. 2009, 35:438-449.
30. Ferguson K.K., Loch-Caruso R., Meeker J.D. Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006. Environ. Res. 2011, 111:718-726.
31. Ferguson K.K., McElrath T.F., Ko Y.A., Mukherjee B., Meeker J.D. Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. Environ. Int. 2014, 70:118-124.
32. Ferguson K.K., McElrath T.F., Meeker J.D. Environmental phthalate exposure and preterm birth. JAMA Pediatr. 2014, 168:61-67. (Erratum in: JAMA Pediatr 2014;168:684).
33. Frederiksen H., Skakkebaek N.E., Andersson A.M. Metabolism of phthalates in humans. Mol. Nutr. Food Res. 2007, 51:899-911.
34. Fujii S., Yabe K., Furukawa M., Hirata M., Kiguchi M., Ikka T. A two-generation reproductive toxicity study of diethyl phthalate (DEP) in rats. J. Toxicol. Sci. 2005, 30:97-116.
35. Gaspari L., Paris F., Jandel C., Kalfa N., Orsini M., Daurès J.P., et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study. Hum. Reprod. Oxf. Engl. 2011, 26:3155-3162.
36. Gray L.E., Ostby J., Furr J., Price M., Veeramachaneni D.N., Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 2000, 58:350-365.
37. Gray L.E., Laskey J., Ostby J. Chronic di-n-butyl phthalate exposure in rats reduces fertility and alters ovarian function during pregnancy in female Long Evans hooded rats. Toxicol. Sci. 2006, 93:189-195.
38. Guo Y., Kannan K. A survey of phthalates and parabens in personal care products from the United States and its implications for human exposure. Environ. Sci. Technol. 2013, 47:14442-14449.
39. Han S., Ritzenthaler J.D., Wingerd B., Roman J. Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta. J. Biol. Chem. 2005, 280:33240-33249.
40. Hauser R., Meeker J.D., Park S., Silva M.J., Calafat A.M. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 2004, 112:1734-1740.
41. Heazell A.E., Moll S.J., Jones C.J., Baker P.N., Crocker I.P. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta 2007, 28(Suppl. A):33-40.
42. Högberg J., Hanberg A., Berglund M., Skerfving S., Remberger M., Calafat A.M., et al. Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations. Environ. Health Perspect. 2008, 116:334-339.
43. Huang P.C., Kuo P.L., Guo Y.L., Liao P.C., Lee C.C. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum. Reprod. 2007, 22:2715-2722.
44. Huang P.C., Kuo P.L., Chou Y.Y., Lin S.J., Lee C.C. Association between prenatal exposure to phthalates and the health of newborns. Environ. Int. 2009, 35:14-20.
45. Huang Y., Li J., Garcia J.M., Lin H., Wang Y., Yan P., et al. Phthalate levels in cord blood are associated with preterm delivery and fetal growth parameters in Chinese women. PLoS ONE 2014, 9:e87430.
46. Hubinger J.C. A survey of phthalate esters in consumer cosmetic products. J. Cosmet. Sci. 2010, 61:457-465.
47. Hurst C.H., Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci. 2003, 74:297-308.
48. Itoh H., Yoshida K., Masunaga S. Quantitative identification of unknown exposure pathways of phthalates based on measuring their metabolites in human urine. Environ. Sci. Technol. 2007, 41:4542-4547.
49. Jensen M.S., Norgaard-Pedersen B., Toft G., Hougaard D.M., Bonde J.P., Cohen A., et al. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environ. Health Perspect. 2012, 120:897-903.
50. Jensen M.S., Anand-Ivell R., Nørgaard-Pedersen B., Jönsson B.A., Bonde J.P., Hougaard D.M., et al. Amniotic fluid phthalate levels and male fetal gonad function. Epidemiology 2015, 26:91-99.
51. Johns L.E., Ferguson K.K., Soldin O.P., Cantonwine D.E., Rivera-González L.O., Del Toro L.V., et al. Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: a longitudinal analysis. Reprod. Biol. Endocrinol. 2015, 13:4.
52. Jurewicz J., Hanke W. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int. J. Occup. Med. Environ. Health 2011, 24:115-141.
53. Kato K., Silva M.J., Brock J.W., Reidy J.A., Malek N.A., Hodge C.C., et al. Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 2003, 27:284-289.
54. Kay V.R., Chambers C., Foster W.G. Reproductive and developmental effects of phthalate diesters in females. Crit. Rev. Toxicol. 2013, 43:200-219.
55. Kay V.R., Bloom M.S., Foster W.G. Reproductive and developmental effects of phthalate diesters in males. Crit. Rev. Toxicol. 2014, 44:467-498.
56. Koch H.M., Rossbach B., Drexler H., Angerer J. Internal exposure of the general population to DEHP and other phthalates-determination of secondary and primary phthalate monoester metabolites in urine. Environ. Res. 2003, 93:177-185.
57. Koch H.M., Bolt H.M., Preuss R., Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch. Toxicol. 2005, 79:367-376.
58. Koch H.M., Christensen K.L., Harth V., Lorber M., Brüning T. Di-n-butyl phthalate (DnBP) and diisobutyl phthalate (DiBP) metabolism in a human volunteer after single oral doses. Arch. Toxicol. 2012, 86:1829-1839.
59. Latini G., De Felice C., Presta G., Del Vecchio A., Paris I., Ruggieri F., et al. In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ. Health Perspect. 2003, 111:1783-1785.
60. Li L., Bu T., Su H., Chen Z., Liang Y., Zhang G., et al. In utero exposure to diisononyl phthalate caused testicular dysgenesis of rat fetal testis. Toxicol. Lett. 2015, 232:466-474.
61. Lin L.C., Wang S.L., Chang Y.C., Huang P.C., Cheng J.T., Su P.H., et al. Associations between maternal phthalate exposure and cord sex hormones in human infants. Chemosphere 2011, 83:1192-1199.
62. Loane M., Dolk H., Kelly A., Teljeur C., Greenlees R., Densem J. EUROCAT Working Group. Paper 4: EUROCAT statistical monitoring: identification and investigation of ten year trends of congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 2011, 91(Suppl. 1):31-43.
63. Lyche J.L., Gutleb A.C., Bergman A., Eriksen G.S., Murk A.J., Ropstad E., et al. Reproductive and developmental toxicity of phthalates. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12:225-249.
64. Main K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ. Health Perspect. 2006, 114:270-276.
65. Mamelle N., Boniol M., Rivière O., Joly M.O., Mellier G., Maria B., et al. Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential. Eur. J. Pediatr. 2006, 165:717-725.
66. Martino-Andrade A.J., Chahoud I. Reproductive toxicity of phthalate esters. Mol. Nutr. Food Res. 2010, 54:148-157.
67. Meeker J.D. Exposure to environmental endocrine disruptors and child development. Arch. Pediatr. Adolesc. Med. 2012, 166:952-958.
68. Meeker J.D., Hu H., Cantonwine D.E., Lamadrid-Figueroa H., Calafat A.M., Ettinger A.S., et al. Urinary phthalate metabolites in relation to preterm birth in Mexico city. Environ. Health Perspect. 2009, 117:1587-1592.
69. Meeker J.D., Sathyanarayana S., Swan S.H. Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364:2097-2113.
70. Nafee T.M., Farrell W.E., Carroll W.D., Fryer A.A., Ismail K.M. Epigenetic control of fetal gene expression. BJOG 2008, 115:158-168.
71. Nassar N., Abeywardana P., Barker A., Bower C. Parental occupational exposure to potential endocrine disrupting chemicals and risk of hypospadias in infants. Occup. Environ. Med. 2010, 67:585-589.
72. Nishioka J., Iwahara C., Kawasaki M., Yoshizaki F., Nakayama H., Takamori K., et al. Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages. Inflamm. Res. 2012, 61:69-78.
73. Ormond G., Nieuwenhuijsen M.J., Nelson P., Toledano M.B., Iszatt N., Geneletti S., et al. Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of hypospadias: case-control study. Environ. Health Perspect. 2009, 117:303-307.
74. Ostrea E.M., Bielawski D.M., Posecion N.C., Corrion M., Villanueva-Uy E., Jin Y., et al. A comparison of infant hair, cord blood and meconium analysis to detect fetal exposure to environmental pesticides. Environ. Res. 2008, 106:277-283.
75. Ozlü T., Güngör A.C., Dönmez M.E., Duran B. Use of progestogens in pregnant and infertile patients. Arch. Gynecol. Obstet. 2012, 286:495-503.
76. Panaretto K., Lee H., Mitchell M., Larkins S., Manessis V., Buettner P., et al. Risk factors for preterm, low birth weight and small for gestational age birth in urban Aboriginal and Torres Strait Islander women in Townsville. Aust. N. Z. J. Public Health 2006, 30:163-170.
77. Philippat C., Mortamais M., Chevrier C., Petit C., Calafat A.M., Ye X., et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ. Health Perspect. 2012, 120:464-470.
78. Poppe K., Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum. Reprod. Update 2003, 9:149-161.
79. Sadler T.W. Susceptible periods during embryogenesis of the heart and endocrine glands. Environ. Health Perspect. 2000, 108:555-561.
80. Salazar-Martinez E., Romano-Riquer P., Yanez-Marquez E., Longnecker M.P., Hernandez-Avila M. Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ. Health 2004, 3:8.
81. Saravanabhavan G., Murray J. Human biological monitoring of diisononyl phthalate and diisodecyl phthalate: a review. J. Environ. Public Health 2012, 2012:810501.
82. Sathyanarayana S., Barrett E., Butts S., Wang C., Swan S.H. Phthalate exposure and reproductive hormone concentrations in pregnancy. Reproduction 2014, 147:401-409.
83. Schettler T. Human exposure to phthalates via consumer products. Int. J. Androl. 2006, 29:134-139.
84. Schindler A.E. First trimester endocrinology: consequences for diagnosis and treatment of pregnancy failure. Gynecol. Endocrinol. 2004, 18:51-57.
85. Sharpe R.M. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:91-110.
86. Shen O., Du G., Sun H., Wu W., Jiang Y., Song L., et al. Comparison of in vitro hormone activities of selected phthalates using reporter gene assays. Toxicol. Lett. 2009, 191:9-14.
87. Silva M.J., Reidy J.A., Herbert A.R., Preau J.L., Needham L.L., Calafat A.M. Detection of phthalate metabolites in human amniotic fluid. Bull. Environ. Contam. Toxicol. 2004, 72:1226-1231.
88. Snijder C.A., Roeleveld N., Te Velde E., Steegers E.A.P., Raat H., Hofman A., et al. Occupational exposure to chemicals and fetal growth: the Generation R Study. Hum. Reprod. 2012, 27:910-920.
89. Snijder C.A., Vlot I.J., Burdorf A., Obermann-Borst S.A., Helbing W.A., Wildhagen M.F., et al. Congenital heart defects and parental occupational exposure to chemicals. Hum. Reprod. 2012, 27:1510-1517.
90. Suzuki Y., Niwa M., Yoshinaga J., Mizumoto Y., Serizawa S., Shiraishi H. Prenatal exposure to phthalate esters and PAHs and birth outcomes. Environ. Int. 2010, 36:699-704.
91. Suzuki Y., Yoshinaga J., Mizumoto Y., Serizawa S., Shiraishi H. Foetal exposure to phthalate esters and anogenital distance in male newborns. Int. J. Androl. 2012, 35:236-244.
92. Svechnikova I., Svechnikov K., Söder O. The influence of di-(2-ethylhexyl) phthalate on steroidogenesis by the ovarian granulosa cells of immature female rats. J. Endocrinol. 2007, 194:603-609.
93. Swan S.H. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ. Res. 2008, 108:177-184.
94. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 2005, 113:1056-1061.
95. Swan S.H., Sathyanarayana S., Barrett E.S., Janssen S., Liu F., Nguyen R.H., et al. TIDES Study Team. First trimester phthalate exposure and anogenital distance in newborns. Hum. Reprod. 2015, 30:963-972.
96. Tetz L.M., Cheng A.A., Korte C.S., Giese R.W., Wang P., Harris C., et al. Mono-2-ethylhexyl phthalate induces oxidative stress responses in human placental cells in vitro. Toxicol. Appl. Pharmacol. 2013, 268:47-54.
97. Thankamony A., Ong K.K., Dunger D.B., Acerini C.L., Hughes I.A. Anogenital distance from birth to 2years: a population study. Environ. Health Perspect. 2009, 117:1786-1790.
98. Valvi D., Monfort N., Ventura R., Casas M., Casas L., Sunyer J., et al. Variability and predictors of urinary phthalate metabolites in Spanish pregnant women. Int. J. Hyg. Environ. Health 2015, 218:220-231.
99. Vrijheid M., Armstrong B., Dolk H., van Tongeren M., Botting B. Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals. Occup. Environ. Med. 2003, 60:543-550.
100. Wagner-Mahler K., Kurzenne J.-Y., Delattre I., Bérard E., Mas J.-C., Bornebush L., et al. Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from Nice area, France. Int. J. Androl. 2011, 34:e499-e510.
101. Wang C., Xie L., Zhou K., Zhan Y., Li Y., Li H., et al. Increased risk for congenital heart defects in children carrying the ABCB1 gene C3435T polymorphism and maternal periconceptional toxicants exposure. PLoS ONE 2013, 8:e68807.
102. Wang C., Zhan Y., Wang F., Li H., Xie L., Liu B., et al. Parental occupational exposures to endocrine disruptors and the risk of simple isolated congenital heart defects. Pediatr. Cardiol. 2015, 36:1024-1037.
103. Weinberger B., Vetrano A.M., Archer F.E., Marcella S.W., Buckley B., Wartenberg D., et al. Effects of maternal exposure to phthalates and bisphenol A during pregnancy on gestational age. J. Matern.-Fetal Neonatal. Med. 2014, 27:323-327.
104. Welsh M., Saunders P.T., Fisken M., Scott H.M., Hutchison G.R., Smith L.B., et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J. Clin. Invest. 2008, 118:1479-1490.
105. Whyatt R.M., Adibi J.J., Calafat A.M., Camann D.E., Rauh V., Bhat H.K., et al. Prenatal di(2-ethylhexyl)phthalate exposure and length of gestation among an inner-city cohort. Pediatrics 2009, 124:e1213-e1220.
106. Wijnands K.P., Zeilmaker G.A., Meijer W.M., Helbing W.A., Steegers-Theunissen R.P. Periconceptional parental conditions and perimembranous ventricular septal defects in the offspring. Birth Defects Res. A Clin. Mol. Teratol. 2014, 100:944-950.
107. Wilson V.S., Lambright C., Furr J., Ostby J., Wood C., Held G., et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol. Lett. 2004, 146:207-215.
108. Wittassek M., Angerer J. Phthalates: metabolism and exposure. Int. J. Androl. 2008, 31:131-138.
109. Wittassek M., Angerer J., Kolossa-Gehring M., Schäfer S.D., Klockenbusch W., Dobler L., et al. Fetal exposure to phthalates - a pilot study. Int. J. Hyg. Environ. Health 2009, 212:492-498.
110. Wittassek M., Koch H.M., Angerer J., Brüning T. Assessing exposure to phthalates - the human biomonitoring approach. Mol. Nutr. Food Res. 2011, 55:7-31.
111. Wolff M.S., Engel S.M., Berkowitz G.S., Ye X., Silva M.J., Zhu C., et al. Prenatal phenol and phthalate exposures and birth outcomes. Environ. Health Perspect. 2008, 116:1092-1097.
112. Wu M.T., Wu C.F., Chen B.H., Chen E.K., Chen Y.L., Shiea J., et al. Intake of phthalate-tainted foods alters thyroid functions in Taiwanese children. PLoS ONE 2013, 8:e55005.
113. Xu Y., Cohen Hubal E.A., Little J.C. Predicting residential exposure to phthalate plasticizer emitted from vinyl flooring: sensitivity, uncertainty, and implications for biomonitoring. Environ. Health Perspect. 2010, 118:253-258.
114. Zhai W., Huang Z., Chen L., Feng C., Li B., Li T. Thyroid endocrine disruption inzebrafish larvae after exposure to mono-(2-ethylhexyl) phthalate (MEHP). PLoS ONE 2014, 9:e92465.
115. Zhang Y., Lin L., Cao Y., Chen B., Zheng L., Ge R.S. Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J. Pediatr. 2009, 155:500-504.